Dr. Deepa Jeyakumar
Claim this profileUC Irvine Health/Chao Family Comprehensive Cancer Center
Expert in Leukemia
Expert in Acute Myeloid Leukemia
20 reported clinical trials
47 drugs studied
About Deepa Jeyakumar
Education:
- Earned a Medical degree (MD) from an unspecified institution.
Experience:
- Specializes in hematologic malignancies, with a focus on acute myeloid leukemia.
- Serves as Co-leader of the Hematologic Malignancies Disease Oriented Team at UCI School of Medicine.
- Affiliated with UCI Health Chao Family Comprehensive Cancer Center, an NCI-designated comprehensive cancer center.
- Active participant in the Southwest Oncology Group (SWOG) for NCI-funded clinical trials.
- Involved in the University of California's collaborative efforts for early phase and investigator-initiated clinical studies.
Area of expertise
1Leukemia
Global LeaderBCR-ABL1 positive
IDH positive
Philadelphia chromosome positive
2Acute Myeloid Leukemia
Global LeaderIDH positive
LILRB4 positive
FLT3 positive
Affiliated Hospitals
Clinical Trials Deepa Jeyakumar is currently running
HMPL-306
for Blood Cancers
An open label single-arm clinical trial to evaluate the safety, tolerability, PK, PD, and preliminary efficacy of HMPL-306 in subjects with advanced relapsed, refractory, or resistant hematological malignancies that harbor IDH mutations.
Recruiting1 award Phase 13 criteria
Venetoclax + ASTX727
for Chronic Myelomonocytic Leukemia
This trial is testing if a combination of two drugs, ASTX727 and venetoclax, is more effective than ASTX727 alone in treating certain bone marrow cancers. It focuses on patients with CMML and MDS/MPN who have too many immature blood cells. ASTX727 helps produce normal blood cells and kills abnormal ones, while venetoclax blocks a protein that cancer cells need to survive. Venetoclax is an anticancer drug used to treat lymphomas and leukemias, but it has severe side effects.
Recruiting1 award Phase 2
More about Deepa Jeyakumar
Clinical Trial Related3 years of experience running clinical trials · Led 20 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Deepa Jeyakumar has experience with
- Cytarabine
- Venetoclax
- Azacitidine
- Blinatumomab
- Pembrolizumab
- Inotuzumab Ozogamicin
Breakdown of trials Deepa Jeyakumar has run
Leukemia
Acute Myeloid Leukemia
Myeloid Leukemia
Myelodysplastic Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Deepa Jeyakumar specialize in?
Deepa Jeyakumar focuses on Leukemia and Acute Myeloid Leukemia. In particular, much of their work with Leukemia has involved BCR-ABL1 positive patients, or patients who are IDH positive.
Is Deepa Jeyakumar currently recruiting for clinical trials?
Yes, Deepa Jeyakumar is currently recruiting for 8 clinical trials in Orange California. If you're interested in participating, you should apply.
Are there any treatments that Deepa Jeyakumar has studied deeply?
Yes, Deepa Jeyakumar has studied treatments such as Cytarabine, Venetoclax, Azacitidine.
What is the best way to schedule an appointment with Deepa Jeyakumar?
Apply for one of the trials that Deepa Jeyakumar is conducting.
What is the office address of Deepa Jeyakumar?
The office of Deepa Jeyakumar is located at: UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California 92868 United States. This is the address for their practice at the UC Irvine Health/Chao Family Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.